Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

NCT00101816

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institution Anaheim, California, United States
  • Local Institution Los Angeles, California, United States
  • Local Institution Stanford, California, United States
View all 62 locations
View Trial Details
Completed

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

NCT01177371

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
Locations
  • Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

NCT00064285

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +25 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States
View Trial Details

Related conditions